Down syndrome: A cardiovascular perspective

Journal of Intellectual Disability Research

Volumn 53, Issue 5, 2009, Pages 419-425

  Vis, J C ^a,b   Duffels, M G J ^a,b   Winter, M M ^a,b   Weijerman, M E ^c   Cobben, J M ^d   Huisman, S A ^e   Mulder, Barbara J M ^a,f  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d EMMA CHILDREN S HOSPITAL   (Netherlands)

^e Prinsenstichting   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Congenital heart defect; Down syndrome; Pulmonary arterial hypertension; Thyroid related cardiac impairment; Trisomy 21

Indexed keywords

BETA2 INTEGRIN; CELL ADHESION MOLECULE; COLLAGEN TYPE 18; COLLAGEN TYPE 6; CYSTATHIONINE BETA SYNTHASE; ENDOTHELIN RECEPTOR ANTAGONIST; HOMOCYSTEINE; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHROMOSOME 21; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CONGENITAL HEART MALFORMATION; CYTOGENETICS; DOWN SYNDROME; ENVIRONMENTAL FACTOR; EXERCISE; GENE LOCUS; GENE OVEREXPRESSION; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HEREDITY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIFE EXPECTANCY; OBESITY; PREVALENCE; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; TRISOMY 21;

CHROMOSOMES, HUMAN, PAIR 22; CORONARY ARTERY DISEASE; DOWN SYNDROME; DUCTUS ARTERIOSUS, PATENT; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; LIFE EXPECTANCY; PREVALENCE;

EID: 65449181143     PISSN: 09642633     EISSN: 13652788     Source Type: Journal    
DOI: 10.1111/j.1365-2788.2009.01158.x     Document Type: Review

References (58)

1. Ait Yahya-Graison E., Aubert J., Dauphinot L., Rivals I., Prieur M., Golfier G. et al. (2007) Classification of human chromosome 21 gene-expression variations in Down syndrome: Impact on disease phenotypes. American Journal of Human Genetics 81, 475-91.
2. van den Akker M., Maaskant M. A. & van der Meijden R. J. (2006) Cardiac diseases in people with intellectual disability. Journal of Intellectual Disability Research 50, 515-22.
3. American Academy of Pediatrics (2001) Health supervision for children with Down syndrome. Pediatrics 107, 442-9.
4. Baird P. A. & Sadovnick A. D. (1987) Life expectancy in Down syndrome. Journal of Pediatrics 110, 849-54.
5. Baird P. A. & Sadovnick A. D. (1988) Causes of death to age 30 in Down syndrome. American Journal of Human Genetics 43, 239-48.
6. Beange H., McElduff A. & Baker W. (1995) Medical disorders of adults with mental retardation: A population study. American Journal on Mental Retardation 99, 595-604.
7. Bell A. J. & Bhate M. S. (1992) Prevalence of overweight and obesity in Down's syndrome and other mentally handicapped adults living in the community. Journal of Intellectual Disability Research 36, 359-64.
8. Biondi B., Fazio S., Palmieri E. A., Carella C., Panza N., Cittadini A. et al. (1999) Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism 84, 2064-7.
9. Bittles A. H., Bower C., Hussain R. & Glasson E. J. (2007) The four ages of Down syndrome. European Journal of Public Health 17, 221-5.
10. Boushey C. J., Beresford S. A., Omenn G. S. & Motulsky A. G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. Journal of the American Medical Association 274, 1049-57.
11. Cappelli-Bigazzi M., Santoro G., Battaglia C., Palladino M. T., Carrozza M., Russo M. G. et al. (2004) Endothelial cell function in patients with Down's syndrome. American Journal of Cardiology 94, 392-5.
12. Cooney T. P. & Thurlbeck W. M. (1982) Pulmonary hypoplasia in Down's syndrome. New England Journal of Medicine 307, 1170-3.
13. Cousineau A. J., Lauer R. M., Pierpont M. E., Burns T. L., Ardinger R. H., Patil S. R. et al. (1994) Linkage analysis of autosomal dominant atrioventricular canal defects: Exclusion of chromosome 21. Human Genetics 93, 103-8.
14. Di Bello V., Monzani F., Giorgi D., Bertini A., Caraccio N., Valenti G. et al. (2000) Ultrasonic myocardial textural analysis in subclinical hypothyroidism. Journal of the American Society of Echocardiography 13, 832-40.
15. Dillmann W. H. (1990) Biochemical basis of thyroid hormone action in the heart. The American Journal of Medicine 88, 626-30.
16. Dorner K., Gaethke A. S., Tolksdorf M., Schumann K. P. & Gustmann H. (1984) Cholesterol fractions and triglycerides in children and adults with Down's syndrome. Clinica Chimica Acta 142, 307-11.
17. Duffels M. G., Berger R. M., Bresser P., de Bruin-Bon H. A., Hoendermis E. S., Bouma B. J. et al. (2006) Applicability of bosentan in Dutch patients with Eisenmenger syndrome: Preliminary results on safety and exercise capacity. Netherlands Heart Journal 14, 165-70.
18. Duffels M. G., Vis J. C., van Loon R. E., Berger R. M., Hoendermis E. S., van Dijk A. P. et al. (2008) Down patients with Eisenmenger syndrome: Is bosentan treatment an option? International Journal of Cardiology [Epub ahead of print].
19. Engelfriet P. M., Duffels M. G., Moller T., Boersma E., Tijssen J. G., Thaulow E. et al. (2007) Pulmonary arterial hypertension in adults born with a heart septal defect: The Euro Heart Survey on adult congenital heart disease. Heart 93, 682-7.
20. Fallon U. B., Ben-Shlomo Y., Elwood P., Ubbink J. B. & Smith G. D. (2001) Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow-up. Heart 85, 153-8.
21. Formigari R., Di Donato R. M., Gargiulo G., Di C. D., Feltri C., Picchio F. M. et al. (2004) Better surgical prognosis for patients with complete atrioventricular septal defect and Down's syndrome. The Annals of Thoracic Surgery 78, 666-72.
22. Freeman S. B., Bean L. H., Allen E. G., Tinker S. W., Locke A. E., Druschel C. et al. (2008) Ethnicity, sex, and the incidence of congenital heart defects: A report from the National Down Syndrome Project. Genetics in Medicine 10, 173-80.
23. Frid C., Drott P., Lundell B., Rasmussen F. & Anneren G. (1999) Mortality in Down's syndrome in relation to congenital malformations. Journal of Intellectual Disability Research 43, 234-41.
24. Gittenberger-de Groot A. C., Bartram U., Oosthoek P. W., Bartelings M. M., Hogers B., Poelmann R. E. etal. (2003) Collagen type VI expression during cardiac development and in human fetuses with trisomy 21. The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology 275, 1109-16.
25. Goi G., Baquero-Herrera C., Licastro F., Dogliotti G. & Corsi M. M. (2006) Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an 'atheroma-free model': Down's syndrome. Internal Journal of Cardiology 113, 427-9.
26. Gorlin R. J., Cohen M. M. & Hennekam R. C. M. (2001) Syndromes of the Head and Neck, 4th edn. Oxford University Press, Oxford, pp. 35-76.
27. Hals J., Hagemo P. S., Thaulow E. & Sorland S. J. (1993) Pulmonary vascular resistance in complete atrioventricular septal defect. A comparison between children with and without Down's syndrome. Acta Paediatrica 82, 595-8.
28. Kahaly G. J. (2000) Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10, 665-79.
29. Karlsson B., Gustafsson J., Hedov G., Ivarsson S. A. & Anneren G. (1998) Thyroid dysfunction in Down's syndrome: Relation to age and thyroid autoimmunity. Archives of Disease in Childhood 79, 242-5.
30. Korenberg J. R., Bradley C. & Disteche C. M. (1992) Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis. American Journal of Human Genetics 50, 294-302.
31. Licastro F., Marocchi A., Penco S., Porcellini E., Lio D., Dogliotti G. et al. (2006) Does Down's syndrome support the homocysteine theory of atherogenesis? Experience in elderly subjects with trisomy 21. Archives of Gerontology and Geriatrics 43, 381-7.
32. Licastro F., Dogliotti G., Goi G., Malavazos A. E., Chiappelli M. & Corsi M. M. (2007) Oxidated low-density lipoproteins (oxLDL) and peroxides in plasma of Down syndrome patients. Archives of Gerontology and Geriatrics 44 (Suppl. 1), 225-32.
33. Lobo E. H., Khan M. & Tew J. (1980) Community study of hypothyroidism in Down's syndrome. British Medical Journal 280, 1253.
34. van Loon R. L., Hoendermis E. S., Duffels M. G., Vonk-Noordegraaf A., Mulder B. J., Hillege H. L. etal. (2007) Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: Does the beneficial effect persist? American Heart Journal 154, 776-82.
35. Marvisi M., Zambrelli P., Brianti M., Civardi G., Lampugnani R. & Delsignore R. (2006) Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. European Journal of Internal Medicine 17, 267-71.
36. Maslen C. L. (2004) Molecular genetics of atrioventricular septal defects. Current Opinion in Cardiology 19, 205-10.
37. Maslen C. L., Babcock D., Redig J. K., Kapeli K., Akkari Y. M. & Olson S. B. (2006) CRELD2: Gene mapping, alternate splicing, and comparative genomic identification of the promoter region. Gene 382, 111-20.
38. Melville C. A., Cooper S. A., McGrother C. W., Thorp C. F. & Collacott R. (2005) Obesity in adults with Down syndrome: A case-control study. Journal of Intellectual Disability Research 49, 125-33.
39. Murdoch J. C., Rodger J. C., Rao S. S., Fletcher C. D. & Dunnigan M. G. (1977) Down's syndrome: An atheroma-free model? British Medical Journal 2, 226-8.
40. Nagyova A., Sustrova M. & Raslova K. (2000) Serum lipid resistance to oxidation and uric acid levels in subjects with Down's syndrome. Physiological Research 49, 227-31.
41. Pogribna M., Melnyk S., Pogribny I., Chango A., Yi P. & James S. J. (2001) Homocysteine metabolism in children with Down syndrome: In vitro modulation. American Journal of Human Genetics 69, 88-95.
42. Prandini P., Deutsch S., Lyle R., Gagnebin M., Delucinge V. C., Delorenzi M. etal. (2007) Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. American Journal of Human Genetics 81, 252-63.
43. Prasher V. P. (1995) Overweight and obesity amongst Down's syndrome adults. Journal of Intellectual Disability Research 39, 437-41.
44. Pueschel S. M., Jackson I. M., Giesswein P., Dean M. K. & Pezzullo J. C. (1991) Thyroid function in Down syndrome. Research in Developmental Disabilities 12, 287-96.
45. Roizen N. J. & Patterson D. (2003) Down's syndrome. Lancet 361, 1281-9.
46. Roth G. M., Sun B., Greensite F. S., Lott I. T. & Dietrich R. B. (1996) Premature aging in persons with Down syndrome: MR findings. American Journal of Neuroradiology 17, 1283-9.
47. Rubello D., Pozzan G. B., Casara D., Girelli M. E., Boccato S., Rigon F. etal. (1995) Natural course of subclinical hypothyroidism in Down's syndrome: Prospective study results and therapeutic considerations. Journal of Endocrinological Investigation 18, 35-40.
48. Saffirio C., Marino B. & Formigari R. (2008) Better surgical prognosis for patients with Down syndrome. The Journal of Thoracic and Cardiovascular Surgery 135, 230.
49. Sare Z., Ruvalcaba R. H. & Kelley V. C. (1978) Prevalence of thyroid disorder in Down syndrome. Clinical Genetics 14, 154-8.
50. Siu C. W., Zhang X. H., Yung C., Kung A. W., Lau C. P. & Tse H. F. (2007) Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: A prospective echocardiographic study. The Journal of Clinical Endocrinology and Metabolism 92, 1736-42.
51. Suzuki K., Yamaki S., Mimori S., Murakami Y., Mori K., Takahashi Y. etal. (2000) Pulmonary vascular disease in Down's syndrome with complete atrioventricular septal defect. American Journal of Cardiology 86, 434-7.
52. Toscano E., Pacileo G., Limongelli G., Verrengia M., Di M. O., Di M. S. etal. (2003) Subclinical hypothyroidism and Down's syndrome; studies on myocardial structure and function. Archives of Disease in Childhood 88, 1005-8.
53. van Trotsenburg A. S. (2006) Early Development and the Thyroid Hormone in Down Syndrome. University of Amsterdam, Amsterdam, the Netherlands.
54. van Trotsenburg A. S., Vulsma T., van Rozenburg-Marres S. L., van Baar A. L., Ridder J. C., Heymans H. S. etal. (2005) The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: A randomized clinical trial. Journal of Clinical Endocrinology and Metabolism 90, 3304-11.
55. Weijerman M. E., van Furth A. M., Vonk N. A., van Wouwe J. P., Broers C. J. & Gemke R. J. (2008) Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: A national study. Journal of Pediatrics 152, 15-19.
56. Wilson L., Curtis A., Korenberg J. R., Schipper R. D., Allan L., Chenevix-Trench G. et al. (1993) A large, dominant pedigree of atrioventricular septal defect (AVSD): Exclusion from the Down syndrome critical region on chromosome 21. American Journal of Human Genetics 53, 1262-8.
57. Yamaki S., Yasui H., Kado H., Yonenaga K., Nakamura Y., Kikuchi T. etal. (1993) Pulmonary vascular disease and operative indications in complete atrioventricular canal defect in early infancy. The Journal of Thoracic and Cardiovascular Surgery 106, 398-405.
58. Yla-Herttuala S., Luoma J., Nikkari T. & Kivimaki T. (1989) Down's syndrome and atherosclerosis. Atherosclerosis 76, 269-72.